Kalshi is introducing three new features to its election prediction markets to enhance transparency for traders. These include tags for low-volume markets, Brier scores to measure market accuracy against actual election outcomes, and a live activity feed showing individual trades. The move comes as Kalshi observes increased trader interest in local races over national ones and aims to provide clearer insights ahead of the U.S. midterm elections. This effort highlights growing engagement in prediction markets, which have expanded rapidly this year.
Kalshi's new transparency features for election contracts provide context as Pluang's Financials sector shows varied trader behavior. For readers following Financials, here is Pluang's market snapshot as of Oct 07, 2026 01:11 WIB: Among 85 priced US Financial stocks, 54 rose and 28 fell today. WULF rose 1.76% with a typical hold time of 17 days and a strong buy order activity of 84%, contrasting with LU which fell 1.46%, held typically for 13 days, and saw 89% sell orders. BBVA gained 1.52%, held much longer at 82 days, with 100% buy orders.
Constellation Brands reported earnings per share of $3.74, surpassing analyst estimates of $3.55, and revenue of $2.63 billion, exceeding the $2.54 billion forecast. The company saw a 5% increase in beer sales and a 17% rise in wine and spirits sales...
Tilray Brands will announce its fiscal Q1 2027 earnings on October 8, with analysts forecasting a loss of $0.16-$0.19 per share on revenues around $265-$268 million, marking about 26% growth from last year. Investors will focus on cannabis and bevera...
On October 6, 2026, five notable stocks surged between 20.9% and 52.7%, driven by various positive developments. Apimeds Pharmaceuticals rose 52.7% after its subsidiary signed a blockchain contract, while Option Care Health gained 32.7% following a $...
On October 6, five notable stocks saw significant declines, with losses ranging from 17.5% to 50.1%. ArriVent BioPharma's shares plunged 46.9% after its lung cancer treatment failed to meet the primary endpoint in a Phase 3 trial. Armada Acquisition ...
Evercore ISI raised its price target for Marvell Technology to $433 from $275, maintaining an Outperform rating. This follows Marvell's optimistic revenue projections, expecting $20 billion by fiscal 2028 and $70-$90 billion by fiscal 2031, driven by...
